Mabqi is a fully integrated immunotherapy biopharmaceutical company.
Mabqi has raised $5.2M in total funding. The most recent round was Grant. The last funding was announced in February 2025.
Mabqi's investors include Bpifrance.
Mabqi is headquartered in Montpellier, France.
Mabqi is a fully integrated immunotherapy biopharmaceutical company.
Mabqi is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mabqi — Funding & Investors." VCBacked, February 26, 2025, https://www.vcbacked.co/company/mabqi. Accessed September 4, 2026.
VCBacked. (2025). Mabqi — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/mabqi
{{cite web |title=Mabqi — Funding & Investors |url=https://www.vcbacked.co/company/mabqi |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated